Clinical Trial Update: Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating dose-intense radiotherapy with SIB-IMRT for glioblastoma in adults. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Glioblastoma | Phase 1 | Status: COMPLETED